Articles with asabys partners tag

El CDTI Innovación invierte, junto con ASABYS PARTNERS, en ALLOX, empresa que desarrolla una tecnología para la identificación de sitios alostéricos en proteínas clave

• 5 days ago
• ALLOX, CDTI Innovación, ASABYS PARTNERS

El CDTI Innovación, a través de su programa Innvierte, conjuntamente con ASABYS PARTNERS, SGEIC, SA, ha alcanzado un acuerdo con los socios de ALLOSTERY EXPLORATION TECHNOLOGIES, S.L. (en adelante, ...

Augustine Therapeutics raises eur 17 million in a series a first closing to advance lead candidate into clinical development in neurological diseases

• 3 months ago
• Augustine Therapeutics, Asabys Partners, Eli Lilly

Asabys’ portfolio company Cara Care is acquired by Mahana Therapeutics to Become a Global Leader in the Digital Treatment of Digestive Disorders and other Chronic Conditions

• 6 months ago
• Mahana Therapeutics, HiDoc Technologies GmbH, Cara Care, Asabys Partners

Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in...

ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asabys

• 10 months ago
• ALLOX, Asabys Partners, Sabadell Asabys II

ALLOX, a techbio company developing a proprietary technology to design new drugs targeting allosteric sites within oncology and other diseases, announces its incorporation today, as well as the succes...

Sidekick Health, backed by Asabys Partners, announces landmark acquisition, expanding its portfolio to offer regulated Prescription Digital Therapeutics

• 11 months ago
• Sidekick Health, Asabys Partners

Sidekick Health’s recent success in closing its Series B fundraising round in May 2022 laid the foundations for the company to accelerate innovation and drive even greater impact in the digital heal...

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

• 1 year ago
• Gradient Denervation Technologies, Asabys Partners, Thuja Capital, Sofinnova Partners, Sabadell Asabys II

Asabys Partners led the round through its new fund Sabadell Asabys II and was joined by Thuja Capital and founding investor Sofinnova Partners. Gradient was established in 2020 through a €3.5m seed ...

Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys

• 1 year ago
• Sofinnova Partners, CDTI Innovación, BStartup, Asabys Partners, Nuage Therapeutics

The financing round was led by Sofinnova Partners, a leading European venture capital firm in life sciences, and Asabys, a venture capital firm based in Barcelona and specialized in the healthcare sec...

XRHealth and Amelia Virtual Care Announce Merger, Creating the Largest XR Therapeutics Platform in the World

• 1 year ago
• Asabys Partners, Alantra, Banco Sabadell, Amelia Virtual Care, XRHealth

The merger was facilitated by Asabys Partners, a leading Barcelona-based venture capital firm specializing in health innovation and deep tech supported by Banco Sabadell and Alantra, and legacy invest...

Asabys launches a new €200m fund to invest in biotech & healthtech

• 2 years ago
• Sabadell Asabys Health Innovation Investments II, Asabys Partners

Headquartered in Barcelona, Asabys was founded by Josep Ll. Sanfeliu and Clara Campàs in 2018 with the support of Alantra as strategic partner. Banc Sabadell, who was the anchor investor of the firm

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

• 2 years ago
• Asabys Partners, Agomab Therapeutics, Pfizer Breakthrough Growth Initiative

Agomab Therapeutics NV (‘Agomab’) has announced it has extended its Series B financing round with an additional close of $40.5 million (€38.4 million), bringing the total Series B amount raised ...

Amelia Virtual Care welcomes new investors and strengthens its management team

• 2 years ago
• ENDRA, CDTI Innvierte, Sabadell Asabys, Caixa Capital Risc, CG Ventures, Asabys Partners

ENDRA and CDTI Innvierte lead the new investment bringing up to €7million the total funds raised by the company in the last year, together with current investors Sabadell Asabys, Caixa Capital Risc ...

Digital digestive health therapeutic Cara Care lands $7M investment, appoints James Jim Mapes CEO

• 2 years ago
• Cara Care, Sabadell Asabys, Johnson & Johnson, Asabys Partners, Dr. Schär AG

Cara Care announced a $7M equity financing round today led by family-owned international food and nutrition manufacturer Dr. Schär AG, alongside existing investors Sabadell Asabys and Johnson & Johns...